Literature DB >> 19443977

Hepatocellular carcinoma and Crohn's disease: a case report and review.

Hideaki Miura1, Takaaki Kawaguchi, Masakazu Takazoe, Shigehiro Kitamura, Haruki Yamada.   

Abstract

Hepatocellular carcinoma (HCC) is usually known to develop in patients with underlying high-risk liver diseases such as viral hepatitis, cirrhosis and alcohol abuse, whereas reports dealing with HCC in Crohn's disease (CD) are limited. We present a case of HCC, which developed sequentially within a short period in a 52-year-old Japanese man with a 36-year history of CD without risky conditions for HCC. He also had not taken immunosuppressants such as azathioprine. Although the definitive etiological factors contributing to hepatocarcinogenesis in the present case could not be elucidated, further close surveillance is required.

Entities:  

Mesh:

Year:  2009        PMID: 19443977     DOI: 10.2169/internalmedicine.48.1866

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Hepatocellular carcinoma occurring in a Crohn's disease patient.

Authors:  Mitsuaki Ishida; Shigeyuki Naka; Hisanori Shiomi; Tomoyuki Tsujikawa; Akira Andoh; Tamio Nakahara; Yasuharu Saito; Yoshimasa Kurumi; Mikiko Takikita-Suzuki; Fumiyoshi Kojima; Machiko Hotta; Tohru Tani; Yoshihide Fujiyama; Hidetoshi Okabe
Journal:  World J Gastroenterol       Date:  2010-07-07       Impact factor: 5.742

2.  Metastatic hepatocellular carcinoma in a patient with Crohn's disease treated with azathioprine and infliximab: a case report and literature review.

Authors:  Kyle J Fortinsky; Ali Alali; Khursheed Jeejeebhoy; Sandra Fischer; Morris Sherman; Scott Fung
Journal:  Case Rep Gastrointest Med       Date:  2014-12-22

3.  Recurrent Hepatocellular Carcinoma in Patient with Crohn's Disease: Incidental or Expected Outcome of Azathioprine?

Authors:  Youssef Botros; Mary Mathews; Hiren Patel; Nihar Shah; Walid Baddoura; Andrew de la Torre
Journal:  Case Rep Gastrointest Med       Date:  2015-12-14

4.  Hepatobiliary phenotype of individuals with chronic intestinal disorders.

Authors:  Jessica Voss; Carolin V Schneider; Moritz Kleinjans; Tony Bruns; Christian Trautwein; Pavel Strnad
Journal:  Sci Rep       Date:  2021-10-07       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.